Wizermed

We are thrilled to announce that Wizermed has been selected for the fifth edition of Open Accelerator, the Zcube-Zambon Research Venture’s international life sciences acceleration program this year focused on women’s health. Starting from today at the OpenZone scientific campus, we will embark on this incredible journey of growth, opportunity, and networking. Out of 185 applications from around the world, we are proud to be one of the five companies selected for our innovative personalized migraine management product by the esteemed pharmaceutical company Zambon. Participating in this program is a major milestone for our company, further reinforcing our business strategy and commitment to advancing women's health. OpenZone Zambon #womanshealth #femtech #healthcareinnovation #migraine #openaccelerator

We are pleased to announce that Dr. Richard B. Lipton has joined the Wizermed family as our Scientific Advisory Board member. Dr. Lipton is a Professor of Neurology, Epidemiology and Population Health at Albert Einstein College of Medicine, a world leading migraine researcher. Supported by his extensive experiences in the migraine space, Dr. Lipton brings to the table an cutting-edge expertise on migraine innovation. Dr. Lipton has a longstanding interest in using technology to identify and treat predictable headaches. He believes that Wizermed is well positioned to transform migraine care through its novel approaches to collecting and analyzing data.  The vision of Dr. Lipton for a future of patient care for migraine patients aligns with our very mission here at Wizermed. With the addition of Dr. Lipton to our team, WizerMed will aim to reach new heights in treatment for migraine management! #migraineresearch #migraine #migrainemanagement #digitalhealth #medicaldevice richard lipton

We're are welcoming angel investors to join us in developing breakthrough solutions for migraine management. Reach out to explore the terms of our current round. #digitalhealth #healthtech #vc #migraine

🚀 Exciting News Alert! 🚀  We are thrilled to announce the newest additions to Wizermed's Board of Directors: Talor Sax, CEO of eHealth Ventures and a visionary leader in health-tech, and Joseph Rosenblum, Chief Medical Officer at eHealth Ventures bringing 30+ years of expertise in Healthcare IT. Their wealth of experience and strategic insights will undoubtedly propel us to new heights. Welcome aboard!   We're still welcoming angel investors to join us in our exciting venture. Don't miss this opportunity, reach out to explore the incredible terms of our round!! Feel free to reach out to Guy Attar for more information.  #digitalhealth #healthtech #vc #migraine

Join Our Pioneering Migraine Study! 🚀 Sarid Research is proud to partner with Wizermed in a cutting-edge study aimed at combating migraines through AI-driven solutions. Wizermed's solutions have the potential to improve the lives of millions suffering from migraines. If you're located in Israel and suffering from migraines there's an opportunity for you to contribute to this breakthrough in medical research as well: as a participant, you’ll not only help advance migraine research but also receive a Garmin smartwatch ⌚ that plays a crucial role in the AI-driven solutions that Wizermed's team is working on. Ready to be a pioneer? Connect with us at https://lnkd.in/dgwyQZ4y and take a step towards a future free from migraines. Thanks to Dan Yamin, Erez Shmueli, and Guy Attar for the opportunity to collaborate with them on this important project. #MigrainePioneers #AIForGood #ClinicalResearch #SmartTechnology #HealthcareInnovation #ParticipateNow

If you have acquaintances or family in israel who suffers from Migrains, there is the opportunity for them to participate in this breakthrough research. Please share the message with them! Wizermed Garmin

We're #hiring a new Junior Data Scientist (Student Job) in Tel Aviv District. Apply today or share this post with your network.

Excited to be part of HIMSS 2024! Join me in Orlando on March 12-13 and share insights about staying ahead of migraines. Let's connect! #HIMSS2024 #HealthTech #Migraine #digitalhealth Wizermed

We are excited to welcome eHealthVentures aboard as our first investor at Wizermed! Migraines impose a significant burden on the lives of those affected by them. The unpredictability of these attacks exacerbates the challenge, significantly affecting patients’ quality of life. In order to combat chronic migraines, Wizermed is developing “Migraine Predict”—a novel AI-based mobile app designed to predict and manage migraine attacks effectively and to reduce the intensity, duration, and frequency of migraine attacks. This investment marks a significant milestone for our company and sets the stage for an exciting journey ahead. We're incredibly grateful for the confidence and trust that eHealth Ventures has placed in us, and we're committed to delivering outstanding results as we embark on this journey together. eHealthVentures Guy Attar #himss24 #migrainepredict For more reading: https://lnkd.in/drGjVAYr

HIMSS24, the Global Health Conference & Exhibition, is a significant event where professionals gather to discuss health information and technology. Scheduled from March 11 to 15, 2024, it serves as a platform for education, innovation, and collaboration in the healthcare industry. One notable application of artificial intelligence (AI) in healthcare is the Migraine Predict app developed by Wizermed. This app provides personalized predictions of migraine episodes for individuals with intermittent migraines, leveraging machine learning to warn patients of oncoming episodes. If you’re interested in how AI can benefit migraine sufferers, consider scheduling a meeting with our CEO in HIMSS24! 🌐🧠💡 Guy Attar #migraine #migrainerelief #himss2024 #digitalhealth